These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 11710686)
21. Immunohistochemical expression of pl30cas in papillary thyroid carcinoma. Dilek FH; Aktepe F; Sahin DA; Topak N; Dilek ON Int Surg; 2008; 93(3):175-80. PubMed ID: 18828274 [TBL] [Abstract][Full Text] [Related]
22. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling. Murphy KM; Chen F; Clark DP Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics. Abouhashem NS; Talaat SM Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214 [TBL] [Abstract][Full Text] [Related]
24. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases]. Yang QX; Shao CK; Feng ZY; Huang BQ; Han AJ; Xiong M; Zhao WL; Wu TT Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):678-81. PubMed ID: 15958307 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions. Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868 [TBL] [Abstract][Full Text] [Related]
26. The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma. Chandan VS; Faquin WC; Wilbur DC; Khurana KK Cancer; 2006 Oct; 108(5):331-6. PubMed ID: 16944537 [TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis. Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Baloch ZW; Abraham S; Roberts S; LiVolsi VA Hum Pathol; 1999 Oct; 30(10):1166-71. PubMed ID: 10534163 [TBL] [Abstract][Full Text] [Related]
29. Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Khurana KK; Truong LD; LiVolsi VA; Baloch ZW Arch Pathol Lab Med; 2003 May; 127(5):579-83. PubMed ID: 12708901 [TBL] [Abstract][Full Text] [Related]
30. Analysis of lectin binding in benign and malignant thyroid nodules. Sasano H; Rojas M; Silverberg SG Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907 [TBL] [Abstract][Full Text] [Related]
31. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma. Bose D; Das RN; Chatterjee U; Banerjee U Indian J Med Paediatr Oncol; 2012 Apr; 33(2):107-11. PubMed ID: 22988353 [TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases. Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344 [TBL] [Abstract][Full Text] [Related]
33. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [TBL] [Abstract][Full Text] [Related]
34. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma. Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041 [TBL] [Abstract][Full Text] [Related]
35. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study. Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698 [TBL] [Abstract][Full Text] [Related]
36. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis. Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129 [TBL] [Abstract][Full Text] [Related]
37. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid. Aydin O; Yildiz L; Kefeli M; Kandemir B Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of X-linked inhibitor of apoptosis (XIAP) in neoplastic and other thyroid disorders. Xiao GQ; Unger PD; Burstein DE Ann Diagn Pathol; 2007 Aug; 11(4):235-40. PubMed ID: 17630106 [TBL] [Abstract][Full Text] [Related]
39. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985 [TBL] [Abstract][Full Text] [Related]
40. Papillary carcinoma of the thyroid. A histochemical, immunohistochemical and ultrastructural study with special reference to the follicular variant. Eimoto T; Naito H; Hamada S; Masuda M; Harada T; Kikuchi M Acta Pathol Jpn; 1987 Oct; 37(10):1563-79. PubMed ID: 3434281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]